Advanced Oncotherapy (LON:AVO) issued its earnings results on Monday. The company reported GBX (9.83) (($0.12)) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of GBX (8.90) (($0.11)) by GBX (0.93) (($0.01)), Bloomberg Earnings reports.
Shares of LON AVO opened at GBX 26 ($0.32) on Wednesday. The company’s fifty day simple moving average is GBX 26.61 and its 200 day simple moving average is GBX 32.04. Advanced Oncotherapy has a 12-month low of GBX 20 ($0.25) and a 12-month high of GBX 44.50 ($0.55). The firm has a market cap of $79.66 million and a PE ratio of -1.86. The company has a quick ratio of 0.79, a current ratio of 2.16 and a debt-to-equity ratio of 55.71.
About Advanced Oncotherapy
Recommended Story: Buyback For Investors Defined
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.